Quick Links

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the California Board of Registered Nursing (CBRN), Provider Number 16669 to provide continuing medical education for physicians and nurses.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.


PER Pulse™ Recaps for Year in Review™: Clinical Impact of Immunotherapies in the Treatment of Cancer

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca and Incyte Corporation.

Year in Review™: Clinical Impact of Immunotherapies in the Treatment of Cancer

Release Date: March 31, 2017
Expiration Date: March 31, 2018
Media: Internet - based

Activity Overview

This online activity will feature a comprehensive overview of noteworthy data presented at major society meetings, and will include expert discussions on the clinical application of this data and the future direction of immunotherapies within the cancer treatment landscape.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca and Incyte Corporation.

CME/CE Activity Table of Contents

  • Introduction
  • Module 1: Biology and Mechanisms of Immunotherapy Agents
  • Module 2: Personalizing Care: Evolving Evidence on Biomarkers
  • Module 3: Current and Emerging Strategies: Clinical Data
  • Module 4: Optimizing Outcomes and Next Steps in Clinical Trials

Requirements for Successful Completion

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review video files/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Video Files” will be available for your reference.
  • If you close the Web browser after you complete the activity, the “Educational Content” link will disappear, and you will need to review the activity in its entirety to once again access the “Educational Content” link.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Click on the “Request Credits” link at the end of the activity. Take the posttest and pass with a score of 70% or higher, complete the evaluation, and then click on “Request Credits.” Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, radiation oncologists, and pulmonologists involved in the treatment and management of patients with cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals (HCPs) interested in the treatment of cancer may also participate.

Educational Objectives

At the conclusion of this activity, participants should be better prepared to:

  • Examine recent evidence on mechanistic approaches and biomarkers related to the use immunotherapeutic strategies to treat solid and liquid malignancies
  • Describe efficacy and safety results from clinical trials that evaluated immunotherapeutic approaches in frontline and subsequent treatment settings for patients with cancer
  • Detail important remaining clinical questions in the field and highly anticipated ongoing clinical trials that are evaluating emerging immunotherapeutic strategies

Faculty, Staff, and Planners' Disclosures


Roy S. Herbst, MD, PhD
Ensign Professor of Medicine (Medical Oncology)
Professor of Pharmacology
Chief of Medical Oncology
Associate Director for Translational Research
Yale Cancer Center/Smilow Cancer Hospital
New Haven, CT

Disclosure: Grant/Research Support: Genentech, Merck; Consultant: AstraZeneca, Eli Lilly, Genentech/Roche, Merck, Pfizer

Jason J. Luke, MD, FACP
Medical Oncologist
Assistant Professor of Medicine
The University of Chicago Medicine
Chicago, IL

Disclosure: Consultant: Amgen, Array BioPharma, CheckMate, BeneVir Biopharm, Bristol-Myers Squibb, EMD Serono, Merck (unpaid)


Arjun Balar, MD
Assistant Professor of Medicine
Director, Genitourinary Medical Oncology Program
NYU Perlmutter Cancer Center
New York, NY

Disclosure: Consultant: Merck, Novartis, Roche; Shareholder: Abraxis, CytomX, Compugen, Five Prime, Kite Pharma

Tanguy Seiwert, MD
Medical Oncologist
Assistant Professor of Medicine
The University of Chicago Medicine
Chicago, IL

Disclosure: Grant/Research Support: Bristol-Myers Squibb, Innate Pharma, Jounce Therapeutics; Consultant: Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Innate Pharma, Jounce Therapeutics, Eli Lilly, Merck, EMD-Serono

The staff of Physicians' Education Resource®, LLC, has no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of Physicians’ Education Resource®, LLC, (PER®) to ensure the fair balance, independence, objectivity, and scientific objectivity in all of our CME/CE activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

Become a Member

Forgot Password?
Calendar of Events
Filter By